Kits Eyecare Ltd.
KTYCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $159 | $121 | $92 | $82 |
| % Growth | 32.2% | 31.5% | 11.2% | – |
| Cost of Goods Sold | $106 | $80 | $62 | $62 |
| Gross Profit | $54 | $41 | $29 | $21 |
| % Margin | 33.7% | 33.8% | 31.9% | 25.4% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $10 | $8 | $12 | $20 |
| SG&A Expenses | $32 | $25 | $24 | $36 |
| Sales & Mktg Exp. | $22 | $17 | $12 | $16 |
| Other Operating Expenses | $16 | $14 | $10 | $0 |
| Operating Expenses | $48 | $43 | $36 | $38 |
| Operating Income | $5 | -$1 | -$4 | -$17 |
| % Margin | 3.4% | -1.2% | -4.7% | -20.7% |
| Other Income/Exp. Net | -$1 | -$1 | -$2 | -$2 |
| Pre-Tax Income | $4 | -$3 | -$6 | -$19 |
| Tax Expense | $1 | -$1 | -$1 | -$4 |
| Net Income | $3 | -$2 | -$5 | -$15 |
| % Margin | 2% | -1.8% | -5% | -17.7% |
| EPS | 0.099 | -0.071 | -0.15 | -0.47 |
| % Growth | 240.1% | 52.9% | 68.1% | – |
| EPS Diluted | 0.092 | -0.071 | -0.15 | -0.47 |
| Weighted Avg Shares Out | 32 | 31 | 30 | 31 |
| Weighted Avg Shares Out Dil | 34 | 31 | 31 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $1 | $2 | $2 | $1 |
| Depreciation & Amortization | $3 | $3 | $2 | $2 |
| EBITDA | $8 | $2 | -$2 | -$15 |
| % Margin | 5.2% | 1.5% | -2.1% | -18.2% |